Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Livestock Dewormers Market

Livestock Dewormers Market Analysis

  • Report ID: GMI12670
  • Published Date: Dec 2024
  • Report Format: PDF

Livestock Dewormers Market Analysis

Based on animal type, the market is segmented into cattle, swine, poultry, and other animal types. The cattle segment dominated the market and was valued at USD 3.6 billion in 2024.
 

  • The high market share of cattle in the market is driven by their significant role in global agriculture and dairy industries.
     
  • Cattle are susceptible to a wide range of parasitic infections, including gastrointestinal worms, which can severely impact growth, milk production, and overall health. Consequently, there is a strong demand for deworming products tailored to cattle.
     
  • Additionally, the increasing adoption of intensive farming practices, rising awareness among farmers regarding the economic benefits of routine deworming, and growing emphasis on food safety further propel the demand for cattle-specific dewormers. These factors collectively position cattle as the dominant segment in the market.
     

Based on the drug class, the livestock dewormers market is categorized into benzimidazoles, macrocyclic lactones, imidazothiazoles, and other drug classes. The macrocyclic lactones segment accounted for the highest market share of 41% in 2024.
 

  • High adoption of macrocyclic lactones dewormers can be attributed to their broad-spectrum efficacy, ease of administration, and extended duration of action. These compounds, including ivermectin, moxidectin, and doramectin, are highly effective against internal parasites such as gastrointestinal worms, making them a versatile solution for livestock health management.
     
  • Additionally, the availability of macrocyclic lactones in various formulations, such as injectables, pour-ons, and drenches, enhances their usability across diverse livestock species, further boosting segmental growth.
     

Based on the mode, the global market is divided into OTC and prescription. The OTC segment is anticipated to reach USD 8.4 billion by 2034.
 

  • The over the counter (OTC) segment holds a significant market share in the livestock dewormers market due to its accessibility, cost-effectiveness, and ease of use. Farmers and livestock owners prefer OTC dewormers as they do not require a veterinary prescription, reducing the time and expenses associated with professional consultations.
     
  • Furthermore, the availability of a wide range of OTC formulations tailored to different livestock species enhances convenience, fueling their popularity.
     
  • The rising global demand for meat, milk, and other livestock products also propels the need for effective parasitic control, solidifying the OTC segment's dominance in this market.
     
Livestock Dewormers Market, By Route of Administration (2024)

Based on route of administration, the market is categorized into oral, topical, and parenteral. The oral segment dominated the market in 2024.
 

  • Factors such as the ease of administration, cost-effectiveness, and widespread availability of oral dewormers solidify its market share in the livestock dewormers market.
     
  • Oral dewormers, including tablets, boluses, and powders, are preferred by livestock owners for their convenience in dosing and minimal requirement for specialized equipment or training. These products offer efficient delivery of active ingredients to target internal parasites, ensuring optimal absorption and efficacy.
     
  • Furthermore, advancements in formulation technologies, such as slow-release boluses, have enhanced the appeal of oral dewormers.
     

Based on distribution channel, the global livestock dewormers market is categorized into veterinary pharmacies, retail pharmacies, and online pharmacies. The veterinary pharmacies segment is anticipated to grow at a CAGR of 4.4% between 2025 – 2034.
 

  • Veterinary pharmacies play a crucial role in the distribution and availability of deworming products, including oral and injectable dewormers, which are essential for maintaining the health and productivity of livestock.
     
  • The growth of this segment is fueled by the rising awareness among farmers about the importance of regular deworming programs to prevent parasitic infections that can affect animal health, reduce productivity, and impact overall farm profitability.
     
  • Additionally, the convenience of purchasing deworming medications from veterinary pharmacies, combined with expert advice from pharmacists and veterinarians, further strengthens their dominance in the market.
     
U.S. Livestock Dewormers Market, 2021 – 2034 (USD Billion)

In 2024, the U.S. held a significant position in the North America livestock dewormers market and was valued at USD 3.1 billion.
 

  • The U.S. agricultural sector's focus on livestock health and productivity, combined with the prevalence of parasitic infections in animals such as cattle, poultry, and swine, has fostered widespread use of deworming products.
     
  • Moreover, the presence of leading pharmaceutical companies and continuous advancements in dewormer formulations further strengthen the market position in the country.
     
  • Additionally, government regulations and veterinary practices that emphasize preventative care and animal welfare contribute to the strong adoption of dewormers across U.S. livestock industries, cementing its dominant market share.
     

Germany shows strong growth potential in the livestock dewormers market.
 

  • Germany exhibits high growth potential in the livestock dewormers market due to its strong agricultural sector and increasing focus on animal health and productivity.
     
  • With a large livestock population, particularly in dairy and beef farming, the demand for effective deworming solutions is rising. For instance, as of November 2023, Germany had 10.8 million cattle, including 3.7 million dairy cows.
     
  • Additionally, the country's stringent regulations around animal welfare and food safety are driving the adoption of advanced deworming products.
     

The livestock dewormers market in Asia Pacific is estimated to grow at a CAGR of 5.5% over the next few years.
 

  • Several factors such as increasing demand for animal protein, rising livestock farming activities, and heightened awareness of animal health are driving the Asia Pacific market.
     
  • As the region continues to experience rapid urbanization and population growth, there is a growing need for sustainable livestock production to meet the dietary requirements of expanding populations. The rising awareness of parasitic infections in livestock, coupled with improved veterinary care, is also fueling the demand for effective deworming treatments.
     
  • Additionally, the adoption of modern farming practices and the increasing number of government initiatives to improve animal health and productivity are further accelerating the market's growth.
     
  • These factors position the Asia Pacific region as a key player in the global market, with ample opportunities for expansion in both established and emerging markets.
     

India is expected to grow significantly during the forecast period.
 

  • As per the 20th Livestock Census 2019, India's extensive livestock population, comprises of approximately 535.8 million cattle, 851.8 million poultry, and 74.3 million sheep. The country's large livestock population, including cattle, poultry, and sheep, creates a substantial demand for deworming products to ensure animal health and productivity.
     
  • Additionally, government initiatives promoting animal health, and the growing export potential of Indian livestock products contribute to market expansion.
     
  • With a focus on improving livestock yields and minimizing losses from parasitic infections, the market in India is poised for significant growth in the coming years.
     

Brazil's livestock dewormers market is projected to witness growth in coming years.
 

  • The country's vast livestock population, coupled with increasing awareness of animal health and productivity, is driving demand for effective deworming solutions.
     
  • Additionally, government initiatives promoting sustainable farming practices and animal welfare are boosting the adoption of veterinary dewormers.
     
  • As Brazil continues to strengthen its position as one of the world’s largest meat exporters, the need for high-quality livestock management, including parasite control, is expected to further fuel market growth.
     

Saudi Arabia is anticipated to grow in the Middle East and African livestock dewormers market.
 

  • The country’s increasing demand for animal products, coupled with the rising awareness of animal health, is driving the adoption of deworming treatments.
     
  • As Saudi Arabia continues to prioritize food security and sustainable agricultural practices, the market is poised for strong development.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global livestock dewormers industry was valued at USD 7.9 billion in 2024 and is projected to grow at a CAGR of 4.8% from 2025 to 2034, driven by increasing demand for animal protein and dairy products worldwide.

The cattle segment accounted for USD 3.6 billion in 2024, dominating the market due to their critical role in global agriculture and dairy industries.

The U.S. livestock dewormers market was valued at USD 3.1 billion in 2024, supported by the agricultural sector's focus on livestock health and the prevalence of parasitic infections in animals like cattle, poultry, and swine.

Key players in the market include Boehringer Ingelheim, Bimeda, Ceva Sante Animale, Durvet, Elanco Animal Health, First Priority, Intas Pharmaceuticals, Jeffers, Manna Pro Products, Merck Animal Health, Phibro Animal Health, and Virbac.

Livestock Dewormers Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 14
  • Tables & Figures: 108
  • Countries covered: 19
  • Pages: 130
 Download Free Sample